Evaluation of the ctDNA LUNAR Test in an Average Coloscopy

Age
45 years - 84 years
Gender
All
participants needed
1000
Location
1
Evaluation of the ctDNA LUNAR Test in an Average Coloscopy

Brief description of study

To see if a blood test called GuardantLUNAR-2 can help detect colorectal cancer or other diseases. The main goal of ECLIPSE is to collect health information and blood samples from people who are at average risk for colorectal cancer and are scheduled to have a colonoscopy screening test.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Coloscopy
  • Age: 45 years - 84 years
  • Gender: All

Male or Female Age 45-84

Updated on 04 Aug 2024. Study ID: 843123
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research